Remember back in the spring when Abbott, Quest and other COVID-19 testing laboratories announcing that test demand was falling fast and cautioning Wall Street investors to tone down their revenue … [Read more...]
EMERGING TESTS
Delta Surge Lifts Demand for COVID-19 Tests & Profits of Laboratories that Produce Them
October 5, 2021
Reproductive Testing
Don’t Rely on Biomarker Tests to Predict Risk of Premature Births, Warns AACC
August 2, 2021
After steadily declining, the rate of spontaneous preterm births in the U.S. rose to 10 percent in 2018. Preventing premature births would save the nation over $26 billion per year. However, … [Read more...]
EMERGING TESTS
New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening
August 2, 2021
Not perfect, but good enough. That is the basic theory for using rapid antigen tests for COVID-19 surveillance even though they are less accurate than molecular assays in detecting the SARS-CoV-2 … [Read more...]
Emerging Tests
New Evidence Supports Suitability of Antigen Testing for COVID-19 Screening
July 29, 2021
Not perfect, but good enough. That is the basic theory for using rapid antigen tests for COVID-19 surveillance even though they are less accurate than molecular assays in detecting the SARS-CoV-2 … [Read more...]
Inside the Diagnostics Industry
Infectious Disease Testing on Path to Steady Growth, Even Without COVID-19
July 1, 2021
From a pure business perspective, the pandemic has been a windfall for Abbott, Cepheid, PerkinElmer, Roche, Thermo Fisher Scientific and other COVID-19 testing companies. However, while the COVID-19 … [Read more...]
Genetic Testing
New Study Supports Use of Liquid Biopsy Technology to Bolster MRI Accuracy in Cancer Treatment
May 1, 2021
Important new evidence has emerged supporting the capabilities of liquid biopsy to enhance the accuracy of magnetic resonance imaging (MRI) for cancer diagnosis and treatment. That evidence comes from … [Read more...]
Testing Strategy
FDA to SARS-CoV-2 Test Developers: Evaluate Impact of Genetic Mutations on Test Performance
March 23, 2021
Evolution and mutation of SARS-CoV-2 virus has made COVID-19 diagnosis a moving target. On Feb. 22, 2021, the U.S. Food and Drug Administration issued new guidance telling developers of SARS-CoV-2 … [Read more...]
Testing Trends
Report Analyzes Federal Health Programs’ COVID-19 Testing Efforts in First Months of Pandemic
February 11, 2021
The COVID-19 outbreak caught the country and the world totally off guard. And even as the pandemic intensifies, the lessons from those first crucial months hold the key to managing not only … [Read more...]
Industry Trends
Surging COVID-19 Cases Are Pushing Laboratories to the Breaking Point
November 21, 2020
Long lines for testing. Shortages of critical testing supplies. Case backlogs and long reporting delays. Laboratories across the country and the patients they serve are reliving the nightmares of … [Read more...]
Testing Strategy
COVID-19 May Spread via Fecal Matter & Not Just Respiratory Droplets
June 23, 2020
It is a truism that almost nobody questions. Because COVID-19 is a respiratory disease, diagnosis and discharge of patients from hospitals is based on respiratory specimens. However, a new analysis … [Read more...]
